Ziwei Xi

463 total citations
24 papers, 301 citations indexed

About

Ziwei Xi is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Ziwei Xi has authored 24 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Cardiology and Cardiovascular Medicine and 3 papers in Molecular Biology. Recurrent topics in Ziwei Xi's work include Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Coronary Interventions and Diagnostics (7 papers) and Lipoproteins and Cardiovascular Health (6 papers). Ziwei Xi is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Coronary Interventions and Diagnostics (7 papers) and Lipoproteins and Cardiovascular Health (6 papers). Ziwei Xi collaborates with scholars based in China. Ziwei Xi's co-authors include Yujie Zhou, Wei Liu, Fang Fang, Jiayang Wang, Wei Liu, Hong Qiu, Ying Yu, Jie Yang, Chunli Shao and Wenyao Wang and has published in prestigious journals such as Atherosclerosis, BMJ Open and Thrombosis Research.

In The Last Decade

Ziwei Xi

24 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziwei Xi China 11 152 126 62 51 41 24 301
Gary E. Meyerrose United States 11 139 0.9× 64 0.5× 48 0.8× 57 1.1× 46 1.1× 21 316
Ramyashree Tummala United States 9 189 1.2× 156 1.2× 27 0.4× 70 1.4× 74 1.8× 18 350
Marco Mennuni Italy 14 311 2.0× 169 1.3× 17 0.3× 69 1.4× 79 1.9× 44 456
Tiong Kiam Ong Malaysia 12 367 2.4× 275 2.2× 30 0.5× 27 0.5× 75 1.8× 34 610
Damras Tresukosol Thailand 11 356 2.3× 368 2.9× 76 1.2× 36 0.7× 96 2.3× 64 562
Fumihiko Kitagawa Japan 13 225 1.5× 76 0.6× 28 0.5× 55 1.1× 22 0.5× 24 486
S J Lin Taiwan 7 120 0.8× 119 0.9× 31 0.5× 72 1.4× 72 1.8× 12 401
Alexander Bufe Germany 13 395 2.6× 194 1.5× 71 1.1× 51 1.0× 45 1.1× 51 540
Chakradhari Inampudi United States 12 217 1.4× 189 1.5× 26 0.4× 32 0.6× 65 1.6× 47 452
Y. Schwartz Israel 10 88 0.6× 64 0.5× 18 0.3× 31 0.6× 44 1.1× 29 314

Countries citing papers authored by Ziwei Xi

Since Specialization
Citations

This map shows the geographic impact of Ziwei Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziwei Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziwei Xi more than expected).

Fields of papers citing papers by Ziwei Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziwei Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziwei Xi. The network helps show where Ziwei Xi may publish in the future.

Co-authorship network of co-authors of Ziwei Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Ziwei Xi. A scholar is included among the top collaborators of Ziwei Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziwei Xi. Ziwei Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Yanan, Hongtao Yang, Qi Feng, et al.. (2024). Long-term efficacy, safety and biocompatibility of a novel sirolimus eluting iron bioresorbable scaffold in a porcine model. Bioactive Materials. 39. 135–146. 4 indexed citations
3.
Yang, Jie, Kuo Zhang, Ziwei Xi, et al.. (2022). Short sleep duration and the risk of nonalcoholic fatty liver disease/metabolic associated fatty liver disease: a systematic review and meta-analysis. Sleep And Breathing. 27(5). 1985–1996. 23 indexed citations
4.
Xi, Ziwei, Hong Qiu, Tingting Guo, et al.. (2022). Contemporary sex differences in mortality among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis. BMJ Open. 12(3). e053379–e053379. 22 indexed citations
5.
Zheng, Jianfeng, Ziwei Xi, Jianan Li, et al.. (2022). Long-term safety and absorption assessment of a novel bioresorbable nitrided iron scaffold in porcine coronary artery. Bioactive Materials. 17. 496–505. 34 indexed citations
6.
Xi, Ziwei, Hong Qiu, Tingting Guo, et al.. (2022). Prevalence, Predictors, and Impact of Coronary Artery Ectasia in Patients With Atherosclerotic Heart Disease. Angiology. 74(1). 47–54. 5 indexed citations
7.
8.
Xi, Ziwei, Jianan Li, Hong Qiu, et al.. (2022). Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry. Platelets. 33(8). 1270–1278. 3 indexed citations
9.
Xi, Ziwei, Jianan Li, Hong Qiu, et al.. (2021). Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease. Frontiers in Cardiovascular Medicine. 8. 768190–768190. 5 indexed citations
10.
11.
Xi, Ziwei, et al.. (2020). The Prognostic Significance of Different Bleeding Classifications in off-pump coronary artery bypass grafting. BMC Cardiovascular Disorders. 20(1). 3–3. 6 indexed citations
12.
Wang, Yushi, Yang Zheng, Qian Tong, et al.. (2020). Cardiac Injury and Clinical Course of Patients With Coronavirus Disease 2019. Frontiers in Cardiovascular Medicine. 7. 147–147. 18 indexed citations
13.
Yu, Ying, Yanli Li, Ziwei Xi, et al.. (2020). Efficacy and Safety of Transcatheter vs. Surgical Aortic Valve Replacement in Low-to-Intermediate-Risk Patients: A Meta-Analysis. Frontiers in Cardiovascular Medicine. 7. 590975–590975. 9 indexed citations
15.
Xi, Ziwei, Yujie Zhou, Yingxin Zhao, et al.. (2020). Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention. Cardiovascular Drugs and Therapy. 34(2). 179–188. 11 indexed citations
16.
Yu, Ying, et al.. (2020). Sodium-glucose cotransporter 2 inhibitors and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Therapeutic Advances in Chronic Disease. 11. 1754253375–1754253375. 15 indexed citations
17.
Xi, Ziwei, Tong Liu, Jing Liang, Yujie Zhou, & Wei Liu. (2019). Impact of postprocedural permanent pacemaker implantation on clinical outcomes after transcatheter aortic valve replacement: a systematic review and meta-analysis. Journal of Thoracic Disease. 11(12). 5130–5139. 16 indexed citations
18.
Wang, Xu, Gaojun Cai, Yingying Wang, et al.. (2019). Comparison of long-term outcomes of young patients after a coronary event associated with familial hypercholesterolemia. Lipids in Health and Disease. 18(1). 131–131. 15 indexed citations
20.
Liu, Wei, et al.. (2018). Impact of major bleeding on the risk of acute kidney injury in patients undergoing off-pump coronary artery bypass grafting. Journal of Thoracic Disease. 10(6). 3381–3389. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026